Distribution consolidation reshapes access to smaller hospital accounts

The European medical device distribution market has been consolidating steadily. Regional wholesalers with strong relationships in a single country are being acquired by larger groups that want pan-European logistics, single-contract purchasing, and a common information system across markets. The pace has slowed since the peak of two years ago, but the direction has not changed, and several mid-sized independents are now reviewing their options with advisers.

For manufacturers the trade-off is familiar. A consolidated partner reduces administrative overhead, offers consistent reporting, and can handle customs, language requirements, and consignment stock in several countries at once. What it cannot always replace is the clinical specialist who knows which procurement committee matters in a mid-sized regional hospital, and who can get a loan kit delivered on a Friday afternoon.

Hospitals notice the change too. Procurement departments that previously negotiated with a local family business now deal with a centralised key account team, and several report slower response on non-standard requests, particularly for loan kits and urgent spare parts. Biomedical engineering teams add that technical escalation paths have lengthened, because the first-line contact no longer has direct access to the manufacturer's service organisation.

Manufacturers with narrow portfolios are responding by keeping direct coverage in their home market and relying on distributors elsewhere. That hybrid model is more expensive to manage, because it requires two sets of commercial processes, but it preserves the technical support that tends to decide competitive tenders in specialised clinical areas such as electrophysiology or robotic surgery. For smaller companies the choice is usually made on cash flow rather than on strategy.